Literature DB >> 22770670

Distinct neural responses used to gain insight into hallucinatory perception in patients with schizophrenia.

Jae-Jin Kim1, Jeonghun Ku, Hyeongrae Lee, Soo Hee Choi, In Young Kim.   

Abstract

OBJECTIVE: Most patients with schizophrenia suffer from various types of hallucinations, which commonly produce distress, functional disability or behavioral dyscontrol. The neural process of adapting to hallucinations in patients with schizophrenia remains unknown.
METHODS: Functional magnetic resonance imaging (MRI) responses to an unusual threatening visual stimulus designed to simulate a hallucinatory experience were compared between 16 patients with schizophrenia and 17 healthy controls. Linear and quadratic repetition-variant as well as repetition-invariant responses to the stimulus were compared between the two groups.
RESULTS: Repetition-invariant responses were similar between patients with schizophrenia and healthy controls. Patients with schizophrenia exhibited a linear activation pattern in the anterior cingulate, whereas healthy controls exhibited a parabolic activation pattern in the anterior prefrontal cortex, occipito-temporal junction and amygdala.
CONCLUSIONS: These results provide us with a better understanding of the neural processes involved in gaining insight into unreality. Patients with schizophrenia may use a salience-related region instead of reality monitoring-related regions to react to the unusual stimuli, and this peculiarity of the neural processes may be related to vulnerability to psychosis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770670     DOI: 10.1016/j.jpsychires.2012.06.012

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  1 in total

1.  The right occipital lobe and poor insight in first-episode psychosis.

Authors:  Diana Tordesillas-Gutierrez; Rosa Ayesa-Arriola; Manuel Delgado-Alvarado; Jennifer L Robinson; Javier Lopez-Morinigo; Jesus Pujol; M Encarnación Dominguez-Ballesteros; Anthony S David; Benedicto Crespo-Facorro
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.